Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis

Author:

Bharat Chrianna1ORCID,Webb Paige1,Wilkinson Zachary1,McKetin Rebecca1ORCID,Grebely Jason2ORCID,Farrell Michael1ORCID,Holland Adam13,Hickman Matthew3ORCID,Tran Lucy Thi1,Clark Brodie1,Peacock Amy14ORCID,Darke Shane1ORCID,Li Jih‐Heng5,Degenhardt Louisa1ORCID

Affiliation:

1. National Drug and Alcohol Research Centre, UNSW Sydney Randwick NSW Australia

2. The Kirby Institute UNSW Sydney Randwick NSW Australia

3. Population Health Sciences, Bristol Medical School University of Bristol Bristol UK

4. School of Psychology University of Tasmania Hobart TAS Australia

5. Doctoral and Master Degree Program in Toxicology, College of Pharmacy Kaohsiung Medical University Kaohsiung Taiwan

Abstract

AbstractBackground and AimsStudies often rely upon self‐report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self‐report instruments. We aimed to examine comprehensively the evidence for agreement between self‐reported and biologically measured illicit drug use among all major illicit drug classes, biological indicators, populations and settings.MethodsWe systematically searched peer‐reviewed databases (Medline, Embase and PsycINFO) and grey literature. Included studies reported 2 × 2 table counts or agreement estimates comparing self‐reported and biologically measured use published up to March 2022. With biological results considered to be the reference standard and use of random‐effect regression models, we evaluated pooled estimates for overall agreement (primary outcome), sensitivity, specificity, false omission rates (proportion reporting no use that test positive) and false discovery rates (proportion reporting use that test negative) by drug class, potential consequences attached to self‐report (i.e. work, legal or treatment impacts) and time‐frame of use. Heterogeneity was assessed by inspecting forest plots.ResultsFrom 7924 studies, we extracted data from 207 eligible studies. Overall agreement ranged from good to excellent (> 0.79). False omission rates were generally low, while false discovery rates varied by setting. Specificity was generally high but sensitivity varied by drug, sample type and setting. Self‐report in clinical trials and situations of no consequences was generally reliable. For urine, recent (i.e. past 1–4 days) self‐report produced lower sensitivity and false discovery rates than past month. Agreement was higher in studies that informed participants biological testing would occur (diagnostic odds ratio = 2.91, 95% confidence interval = 1.25–6.78). The main source of bias was biological assessments (51% studies).ConclusionsWhile there are limitations associated with self‐report and biological testing to measure illicit drug use, overall agreement between the two methods is high, suggesting both provide good measures of illicit drug use. Recommended methods of biological testing are more likely to provide reliable measures of recent use if there are problems with self‐disclosure.

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3